With the bull market in its 10th year, the stock market challenging all-time highs, and assorted economic and political concerns, investors may be considering rotating out of growth stocks and into value stocks – but the author of today’s article advises “value investors had better be very cautious about what sort of ‘value’ they are looking for”, noting that “they often ignore or overlook the signs that a value trap is just about to eat into their assets.” He proceeds to outline “11 specific areas that investors need to consider when it comes to value investing now that the stock market has again challenged new all-time highs.” For more, CLICK HERE.
How can the S&P 500 be underperforming the market when the S&P 500 is the market? Because, as the author of today’s article explains, the S&P 500 isn’t the market and, indeed, “the S&P 500, including dividends, has been underperforming the so-called Total Market Index for over 18½ years.” What are the three primary explanations as to how the total market manages to beat the benchmark – and what are some funds to consider for exposure to the total market (including what may be the best overall total market ETF)? CLICK HERE.
“Making money on marijuana (cannabis with high content of intoxicating THC) and hemp (cannabis that contains low content of THC) will be extremely difficult — except perhaps in one specific area,” advises the author of today’s article, who outlines where he believes the real money in marijuana won’t be made (growers and pharmaceutical companies, to be exact) and that “one specific area” where he believes it will be made. For more, CLICK HERE.
The past few weeks have seen an unusual activity in the tech sector: significant insider buying at more than a dozen tech firms, especially chip companies. As the author of today’s article notes, studies “have consistently shown that buying by corporate insiders often precedes bullish moves in stocks, sectors, and the market overall.” So, despite current worries about the market and the economy, there may be reason to be bullish on tech – and the author highlights a number of tech names that have seen recent insider buying. For more, CLICK HERE.
There’s currently nowhere near the number of retirement facility living units needed to meet the demand that will exist in the coming decades. As such, the author of today’s article declares that “Investing in the companies…that are trying to accomplish housing units for America’s aging population is going to be on the ground floor of the fastest value producing stock ownership trajectory since Amazon, Google, or any other company coattails to have been ridden in the history of the stock market.” For some top retirement facility stock picks to consider to play this trend, CLICK HERE.
It is often stated that society today has become too litigious – but there’s a profit-making opportunity in all that litigiousness. As the author of today’s article notes, “high-visibility trials don’t kill companies—although they do hurt their share price in the short-run. From McDonald’s to the tobacco space, buying during times of literal trial are often the most profitable” – and he highlights one area of litigation currently forming that could prove to be on par with that once faced by the tobacco industry. For more, CLICK HERE.
“This big lie keeps many investors down. Belief in it is a tall hurdle to building wealth,” declares the author of today’s article, who further states that “Like many lies, people tell this one for one of two reasons. Some genuinely don’t know any better. Others are happy to spread it because it’s convenient for them.” What is this big lie (which has to do with risk and reward) that prevents many investors from making big profits – and what are some specific big-profit stocks that help expose this lie for what it is? CLICK HERE.
They are not as rare as their name suggests, but a rare opportunity may be setting up in so-called rare-earth minerals as China considers weaponizing the metals (for which it is responsible for 90% of global production) as part of the ongoing trade war and cutting off export of them to the U.S. Specifically, this opportunity involves investing in non-Chinese rare earth producers, which could benefit from such action by China. For more – including details on the rare earth producers operating in the U.S., Australia and Canada – CLICK HERE.
A health care company whose shares are up 57% in the past year and which, unlike many other health care companies, is not threatened by the possibility of a “Medicare for All” type system (in fact, it could actually benefit from a national health insurance model) leads a selection of stocks that have risen sharply (50% or more) in the past 12 months and appear to have the potential for further gains. For these stocks that may be worthy of consideration, CLICK HERE.